289 related articles for article (PubMed ID: 28106348)
1. A Biosurfactant-Inspired Heptapeptide with Improved Specificity to Kill MRSA.
Liu Y; Ding S; Dietrich R; Märtlbauer E; Zhu K
Angew Chem Int Ed Engl; 2017 Feb; 56(6):1486-1490. PubMed ID: 28106348
[TBL] [Abstract][Full Text] [Related]
2. Anti-staphylococcal activity of a cyclic lipopeptide, C
Nam J; Alam ST; Kang K; Choi J; Seo MH
J Appl Microbiol; 2021 Jul; 131(1):93-104. PubMed ID: 33211361
[TBL] [Abstract][Full Text] [Related]
3. Natural lipopeptide antibiotic tripropeptin C revitalizes and synergistically potentiates the activity of beta-lactams against methicillin-resistant Staphylococcus aureus.
Hashizume H; Takahashi Y; Harada S; Nomoto A
J Antibiot (Tokyo); 2015 Jun; 68(6):373-8. PubMed ID: 25586024
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Linear Low-Cationic Peptides to Target Methicillin-Resistant Staphylococcus aureus in Vivo.
Liu Y; Song M; Ding S; Zhu K
ACS Infect Dis; 2019 Jan; 5(1):123-130. PubMed ID: 30372023
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of newly generated short antimicrobial cationic lipopeptides against methicillin-resistant Staphylococcus aureus (MRSA).
Greber KE; Roch M; Rosato MA; Martinez MP; Rosato AE
Int J Antimicrob Agents; 2020 Mar; 55(3):105827. PubMed ID: 31634552
[TBL] [Abstract][Full Text] [Related]
6. Isolation and identification of lipopeptide antibiotics from Paenibacillus elgii B69 with inhibitory activity against methicillin-resistant Staphylococcus aureus.
Ding R; Wu XC; Qian CD; Teng Y; Li O; Zhan ZJ; Zhao YH
J Microbiol; 2011 Dec; 49(6):942-9. PubMed ID: 22203557
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of two novel antibacterial cyclic hexapeptides from Streptomyces alboflavus 313.
Ji Z; Qiao G; Wei S; Fan L; Wu W
Chem Biodivers; 2012 Aug; 9(8):1567-78. PubMed ID: 22899617
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo activities of novel cyclic lipopeptides against staphylococcal biofilms.
Bionda N; Pastar I; Davis SC; Cudic P
Protein Pept Lett; 2014 Apr; 21(4):352-6. PubMed ID: 24164269
[TBL] [Abstract][Full Text] [Related]
9. Rhodomyrtosone B, a membrane-targeting anti-MRSA natural acylgphloroglucinol from Rhodomyrtus tomentosa.
Zhao LY; Liu HX; Wang L; Xu ZF; Tan HB; Qiu SX
J Ethnopharmacol; 2019 Jan; 228():50-57. PubMed ID: 30195566
[TBL] [Abstract][Full Text] [Related]
10. In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections.
Desbois AP; Gemmell CG; Coote PJ
Int J Antimicrob Agents; 2010 Jun; 35(6):559-65. PubMed ID: 20206480
[TBL] [Abstract][Full Text] [Related]
11. Cyclic lipopeptides as antibacterial agents - potent antibiotic activity mediated by intriguing mode of actions.
Schneider T; Müller A; Miess H; Gross H
Int J Med Microbiol; 2014 Jan; 304(1):37-43. PubMed ID: 24119568
[TBL] [Abstract][Full Text] [Related]
12. Structure-Activity Relationships of Daptomycin Lipopeptides.
Karas JA; Carter GP; Howden BP; Turner AM; Paulin OKA; Swarbrick JD; Baker MA; Li J; Velkov T
J Med Chem; 2020 Nov; 63(22):13266-13290. PubMed ID: 32687352
[TBL] [Abstract][Full Text] [Related]
13. Screening, purification and characterization of thermostable, protease resistant Bacteriocin active against methicillin resistant Staphylococcus aureus (MRSA).
Ansari A; Zohra RR; Tarar OM; Qader SAU; Aman A
BMC Microbiol; 2018 Nov; 18(1):192. PubMed ID: 30466388
[TBL] [Abstract][Full Text] [Related]
14. Anti-infective drug development for MRSA.
Daniel A
Methods Mol Biol; 2014; 1085():311-31. PubMed ID: 24085703
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a novel antibacterial protein CB6-C to target methicillin-resistant Staphylococcus aureus.
Zhang H; Chen J; Liu Y; Xu Q; Inam M; He C; Jiang X; Jia Y; Ma H; Kong L
Microb Cell Fact; 2022 Jan; 21(1):4. PubMed ID: 34983528
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Bioactivities of New Membrane-Active Agents with Aromatic Linker: High Selectivity and Broad-Spectrum Antibacterial Activity.
Chu W; Yang Y; Cai J; Kong H; Bai M; Fu X; Qin S; Zhang E
ACS Infect Dis; 2019 Sep; 5(9):1535-1545. PubMed ID: 31328496
[TBL] [Abstract][Full Text] [Related]
17. In Vitro activity of novel glycopolymer against clinical isolates of multidrug-resistant Staphylococcus aureus.
Narayanaswamy VP; Giatpaiboon SA; Uhrig J; Orwin P; Wiesmann W; Baker SM; Townsend SM
PLoS One; 2018; 13(1):e0191522. PubMed ID: 29342216
[TBL] [Abstract][Full Text] [Related]
18. Linear Analogues of the Lipopeptide Battacin With Potent In Vitro Activity Against S. aureus.
Glossop HD; Pearl E; De Zoysa GH; Sarojini V
Adv Protein Chem Struct Biol; 2018; 112():385-394. PubMed ID: 29680242
[TBL] [Abstract][Full Text] [Related]
19. Potentials of nanotechnology in treatment of methicillin-resistant Staphylococcus aureus.
Gao Y; Chen Y; Cao Y; Mo A; Peng Q
Eur J Med Chem; 2021 Mar; 213():113056. PubMed ID: 33280899
[TBL] [Abstract][Full Text] [Related]
20. Systematic study of non-natural short cationic lipopeptides as novel broad-spectrum antimicrobial agents.
Lohan S; Cameotra SS; Bisht GS
Chem Biol Drug Des; 2013 Nov; 82(5):557-66. PubMed ID: 23819506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
